Connect with us

Technology

Cell Counting Market is expected to generate a revenue of USD 16.5 Billion by 2031, Globally, at 6.20% CAGR: Verified Market Research®

Published

2 years ago

on

The Cell Counting Market is driven by the increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in automated cell counting technologies. Expanding research in life sciences and biotechnology also boosts market growth. However, high costs of advanced instruments, stringent regulatory frameworks, and the lack of skilled professionals in developing regions are significant restraints that could hinder the market’s expansion.

LEWES, Del., Aug. 23, 2024 /PRNewswire/ — The Global Cell Counting Market Size is projected to grow at a CAGR of 6.20% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 10.2 Billion in 2024 and is expected to reach USD 16.5 Billion by the end of the forecast period.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=29479

Browse in-depth TOC on “Global Cell Counting Market Size“

202 – Pages
126 – Tables
37 – Figures

Report Scope

REPORT ATTRIBUTES

DETAILS

STUDY PERIOD

2021-2031

GROWTH RATE

CAGR of ~6.20% from 2024 to 2031

BASE YEAR FOR VALUATION

2024

HISTORICAL PERIOD

2021-2023

FORECAST PERIOD

2024-2031

QUANTITATIVE UNITS

Value in USD Billion

REPORT COVERAGE

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

SEGMENTS COVERED

ProductApplicationEnd-User

 

REGIONS COVERED

North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa

 

KEY PLAYERS

Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company (BD), Merck KGaA, Agilent Technologies, Danaher Corporation, PerkinElmer, Inc., GE Healthcare, Beckman Coulter (a Danaher company), Olympus Corporation, Sysmex Corporation, Miltenyi Biotec, Nexcelom Bioscience, ChemoMetec A/S, DeNovix, Inc., Countstar, Abbott Laboratories, Tecan Group Ltd., Sartorius AG, Promega Corporation

CUSTOMIZATION

Report customization along with purchase available upon request

Global Cell Counting Market Overview

Advancements in Automated Cell Counting Technologies: The Cell Counting Market is experiencing strong expansion as a result of advancements in automated cell counting technology. Advancements in precision, velocity, and user-friendliness are diminishing human mistakes, enhancing the efficiency of tasks, and facilitating the analysis of large volumes of data. These advancements are increasing the demand from biotechnology companies and research laboratories, speeding up the growth of the market and promoting additional investment in automation solutions. The influence is clearly observable in the market’s increasing rate of adoption and continuous expansion.

Rising Prevalence of Chronic Diseases: The rising incidence of chronic illnesses, such as cancer and diabetes, is a major factor contributing to the growth of the Cell Counting Market. The increasing demand for early diagnosis and individualized therapy necessitates accurate cell counting in diagnostic techniques. The current increase in demand is driving the expansion of the market, especially in clinical laboratories and hospitals, where precise cell quantification is crucial for efficient patient care.

Growing Biopharmaceutical Research & Development: Increasing investment in research & development in the biopharmaceutical sector plays a vital role in driving the growth of the Cell Counting Market. The increasing investment by biopharma companies in the development of new medications and cures has led to a growing demand for dependable cell counting technologies in order to ensure precise research results. The increasing popularity of this trend is driving market expansion, directly influencing the use of sophisticated cell counting devices and reagents, resulting in higher sales and market reach.

High Costs of Advanced Cell Counting Instruments: Although sophisticated cell counting devices offer advantages, the substantial expenses connected with them present a significant obstacle in the Cell Counting Market. Smaller research labs and healthcare facilities sometimes struggle to afford these costly technology, which hinders their ability to enter the market. The presence of this financial obstacle is impeding the expansion of the market, particularly in developing areas where limited financial resources are more evident, thereby affecting the overall rate of acceptance.

Stringent Regulatory Requirements: The Cell Counting Market is further hindered by strict regulatory standards that govern the approval and usage of cell counting devices. Manufacturers may experience delays in product launches and incur higher costs due to the intricate and time-consuming nature of regulatory compliance. These limitations impede the expansion of the industry by restricting the accessibility of groundbreaking items and establishing obstacles for new participants in the market.

Limited Technical Expertise: The Cell Counting Market is limited by a scarcity of proficient people with skills in running sophisticated cell counting technologies. The absence of technical expertise can result in subpar utilization of these advanced devices, diminishing their efficacy and discouraging potential purchasers. The effect on market expansion is substantial, especially in areas with limited availability of specialist training and education, which hinders the rate of acceptance.

Key Players

The “Global Cell Counting Market” study report will provide a valuable insight with an emphasis on the global market.  The major players in the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company (BD), Merck KGaA, Agilent Technologies, Danaher Corporation, PerkinElmer, Inc., GE Healthcare, Beckman Coulter (a Danaher company), Olympus Corporation, Sysmex Corporation, Miltenyi Biotec, Nexcelom Bioscience, ChemoMetec A/S, DeNovix, Inc., Countstar, Abbott Laboratories, Tecan Group Ltd., Sartorius AG, Promega Corporation.

Based on the research, Verified Market Research has segmented the global Cell Counting Market into Product, Application, End-User, and Geography.

Cell Counting Market, by Product:InstrumentsSpectrophotometersFlow CytometersHemocytometersAutomated Cell CountersMicroscopesConsumables & AccessoriesReagentsMicroplatesCell Counting Market, by Application:Complete Blood CountAutomated Cell CountersManual Cell CountersStem Cell ResearchCell-Based TherapeuticsBioprocessingToxicologyCell Counting Market, by End-User:Hospitals & Diagnostic LaboratoriesResearch & Academic InstitutesPharmaceutical & Biotechnology CompaniesCell Counting Market, by GeographyNorth AmericaU.SCanadaMexicoEuropeGermanyFranceU.KRest of EuropeAsia PacificChinaJapanIndiaRest of Asia PacificROWMiddle East & AfricaLatin America

Browse Related Reports:

Global Cell-Based Drug Discovery Services Market Size By Type (Cell Line Development, Cell-Based Assays, Cell Culture, High-Content Screening, Phenotypic Screening), By Application (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders, Autoimmune Diseases), By Technology (2D Cell Culture, 3D Cell Culture, CRISPR/Cas9 Genome Editing, Single-Cell Analysis), By End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Geography, And Forecast

Global Live Cell Encapsulation Market Size by Type (Natural Polymers, Synthetic Polymers), By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation), By Method (Microencapsulation, Macroencapsulation, Nanoencapsulation), By Geography, And Forecast

Global Cell Separation Technology Market Size By Product Type (Consumables, Instruments), Application (Stem Cell Research, Cancer Research, Immunology, Drug Discovery and Development), End-User (Biotechnology and Pharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Clinics), By Geography, And Forecast

Global Cell Expansion Market Size By Cell Type (Human Cells, Animal Cells), Application (Regenerative Medicine and Stem Cell Research, Cancer & Cell-Based Research), & End-User (Biopharmaceutical & Biotechnology Companies, Research Institutes), By Geography, And Forecast

Top 7 Cell Culture Companies helping scientific community by growing cells in artificial environment

Visualize Cell Counting Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.

With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.

VMR’s domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.

Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR’s dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
US Toll Free: +1 (800)-782-1768
Email: mailto:sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/cell-counting-market-is-expected-to-generate-a-revenue-of-usd-16-5-billion-by-2031–globally-at-6-20-cagr-verified-market-research-302229452.html

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

XLCS Partners advises Concurrent Utility Services on sale to UniTek Global Services

Published

9 minutes ago

on

July 23, 2026

By

NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ — XLCS Partners, Inc., a leading middle market investment bank, is pleased to announce that it served as exclusive M&A advisor to Concurrent Utility Services LLC on its acquisition by UniTek Global Services, Inc., a portfolio company of New Mountain Finance Corporation (Nasdaq: NMFC) and its affiliates, and BTG Pactual Strategic Capital.

Headquartered in Miami, Florida, Concurrent is a licensed general and electrical contractor providing infrastructure development and maintenance services to electric utilities, telecom providers, and land developers throughout the Southeast United States. The company’s capabilities span overhead and underground utility construction, professional telecom services, emergency service restoration, in-building networks, environmental services, and data center development. Backed by a safety-first culture and an experienced workforce, Concurrent has built a strong regional platform and a reputation for quality across the markets it serves.

UniTek is a leading digital infrastructure services provider supporting the expansion of fiber and data center connectivity across the U.S. and Canada. With over 600 employees and 60 locations, UniTek delivers a full suite of infrastructure services. The acquisition of Concurrent accelerates UniTek’s Power Services Division, which launched in July 2025 to broaden the company’s maintenance, repair, upgrade, and new infrastructure development services for the power sector. Concurrent’s established Southeast footprint and power capabilities directly complement UniTek’s existing broadband and data center infrastructure platform, positioning the combined company to capitalize on growing demand for resilient, modernized power infrastructure. Concurrent will continue to operate under its established brand, maintaining uninterrupted service for its customers.

“Selling Concurrent was one of the biggest decisions of my career, and Anthony, Jay, and the XLCS team guided us through every step with professionalism and genuine care for our people,” said Steve Sarno, CEO of Concurrent. “They stayed fully engaged throughout, gave us honest and thoughtful advice, kept our best interests front and center, and delivered an outcome that exceeded our expectations. I would recommend them without hesitation to any owner considering a transaction.”

XLCS acted as the exclusive M&A advisor to Concurrent, and the transaction was led by Anthony Contaldo, Partner, and Jay Cremer, Vice President. The transaction was completed on July 1, 2026.

About XLCS Partners, Inc.

XLCS Partners is a leading global investment banking firm providing M&A advisory services. Visit www.xlcspartners.com for more information.

Media Contact: 
Kendra Span 
kspan@xlcspartners.com
615-379-7783

View original content to download multimedia:https://www.prnewswire.com/news-releases/xlcs-partners-advises-concurrent-utility-services-on-sale-to-unitek-global-services-302833542.html

SOURCE XLCS Partners, Inc.

Continue Reading

Technology

XLCS Partners advises Concurrent Utility Services on sale to UniTek Global Services

Published

9 minutes ago

on

July 23, 2026

By

NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ — XLCS Partners, Inc., a leading middle market investment bank, is pleased to announce that it served as exclusive M&A advisor to Concurrent Utility Services LLC on its acquisition by UniTek Global Services, Inc., a portfolio company of New Mountain Finance Corporation (Nasdaq: NMFC) and its affiliates, and BTG Pactual Strategic Capital.

Headquartered in Miami, Florida, Concurrent is a licensed general and electrical contractor providing infrastructure development and maintenance services to electric utilities, telecom providers, and land developers throughout the Southeast United States. The company’s capabilities span overhead and underground utility construction, professional telecom services, emergency service restoration, in-building networks, environmental services, and data center development. Backed by a safety-first culture and an experienced workforce, Concurrent has built a strong regional platform and a reputation for quality across the markets it serves.

UniTek is a leading digital infrastructure services provider supporting the expansion of fiber and data center connectivity across the U.S. and Canada. With over 600 employees and 60 locations, UniTek delivers a full suite of infrastructure services. The acquisition of Concurrent accelerates UniTek’s Power Services Division, which launched in July 2025 to broaden the company’s maintenance, repair, upgrade, and new infrastructure development services for the power sector. Concurrent’s established Southeast footprint and power capabilities directly complement UniTek’s existing broadband and data center infrastructure platform, positioning the combined company to capitalize on growing demand for resilient, modernized power infrastructure. Concurrent will continue to operate under its established brand, maintaining uninterrupted service for its customers.

“Selling Concurrent was one of the biggest decisions of my career, and Anthony, Jay, and the XLCS team guided us through every step with professionalism and genuine care for our people,” said Steve Sarno, CEO of Concurrent. “They stayed fully engaged throughout, gave us honest and thoughtful advice, kept our best interests front and center, and delivered an outcome that exceeded our expectations. I would recommend them without hesitation to any owner considering a transaction.”

XLCS acted as the exclusive M&A advisor to Concurrent, and the transaction was led by Anthony Contaldo, Partner, and Jay Cremer, Vice President. The transaction was completed on July 1, 2026.

About XLCS Partners, Inc.

XLCS Partners is a leading global investment banking firm providing M&A advisory services. Visit www.xlcspartners.com for more information.

Media Contact: 
Kendra Span 
kspan@xlcspartners.com
615-379-7783

View original content to download multimedia:https://www.prnewswire.com/news-releases/xlcs-partners-advises-concurrent-utility-services-on-sale-to-unitek-global-services-302833542.html

SOURCE XLCS Partners, Inc.

Continue Reading

Technology

Fathom Applauds Introduction of the FRONTIER Act, the First Federal Blueprint for Independent AI Verification

Published

9 minutes ago

on

July 23, 2026

By

Reps. Lori Trahan (D-MA-03) and Jay Obernolte (R-CA-23) introduce a bill to build a competitive marketplace of independent verifiers for frontier AI models.

WASHINGTON, July 23, 2026 /PRNewswire/ — Fathom welcomes the introduction of the FRONTIER Act, the most complete federal framework yet for independent, third-party verification of frontier AI. The legislation is built to earn public trust as AI technology continues to accelerate. As frontier systems begin to take autonomous action in the world, the gap between what these models can do and our ability to keep them in check is widening. FRONTIER is the starting point to close that gap.

“AI governance keeps running into the same wall. The technology is hard to measure and it moves faster than any law can keep up with,” said Andrew Freedman, Co-Founder and CEO of Fathom. “Trying to write the perfect rules and freezing them in place won’t work. What will work is a competitive market of independent verifiers who are accountable for real-world outcomes and who the government can actually count on. The FRONTIER Act shows we can move fast and still get this right.”

The bill gets the fundamentals correct. It sets one public standard – the adequate mitigation of catastrophic risk – and holds both the AI companies and their independent verifiers accountable to it. FRONTIER does not freeze a single testing method into statute. Instead, it licenses competing verification organizations, allows them to sharpen their methods, and gives the government the power to revoke a license when a verifier’s work does not hold up in the field. That is how you build a system that keeps pace with the science instead of falling behind it.

Fathom thanks Reps. Trahan and Obernolte for their leadership, and for their courage in releasing a discussion draft, inviting scrutiny, and incorporating substantive improvements from across the field. One priority improvement as the bill advances: giving the government a fuller range of tools to act upstream – for pushing companies to close identified gaps in risk mitigation early, rather than only once a catastrophe is imminent. We are committed to working with these sponsors, committees of jurisdiction, and Congressional leadership to continue refining the bill in the weeks and months ahead.

About Fathom
Fathom is an independent nonprofit whose mission is to build a governance architecture that helps society navigate the transition to a world with AI by fostering trust, safety, and innovation. Fathom has developed and championed the independent verification model for AI and works with policymakers across the country to put it into practice. Learn more at http://fathom.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fathom-applauds-introduction-of-the-frontier-act-the-first-federal-blueprint-for-independent-ai-verification-302833546.html

SOURCE Fathom AI Inc.

Continue Reading

Trending